Chronic alcohol consumption can have deleterious effects on the central and peripheral nervous systems. One of the most common adverse effects seen in patients with chronic alcohol use disorder is alcohol neuropathy. This commonly presents with pain, paresthesias, and ataxia in the distal lower extremities. The exact number of people affected by this condition is not known, but studies have shown that up to 66% of patients with chronic alcohol use disorder may have some form of the disease. The cause is multifactorial, from both nutritional deficiencies and alcohol metabolism's direct toxic effects on neurons. History and physical exam can help to differential this condition from other forms of neuropathy. No specific lab test is available for diagnosis. Treatment should be focused on alcohol sobriety and replacement of key nutrients.
The long-term, negative outcomes from alcohol consumption have been well-studied and identified, but the specific causes for these outcomes are not well understood. Multiple components are responsible for the development of alcoholic neuropathy. The duration of alcohol abuse and the lifetime quantity of alcohol consumed are two key elements when studied among patients with chronic alcohol use disorder. One study suggested that a quantity more than 100 g/day over a number of years was likely to cause peripheral neuropathy.
Alcohol is one of the most commonly used substances in the world. Among patients with chronic alcohol use disorder, neuropathy is the most common harmful sequelae. It is estimated that in the United States 25% to 66% of chronic alcohol users experience some form of neuropathy; however, the true incidence in the general population is unknown. The majority of patients were middle-class, working men and continuous drinkers were more affected than episodic drinkers. Parental family history is a risk factor for developing this condition. Women are more likely to develop alcohol polyneuropathy and suffer from a more rapid onset and greater severity.
Alcohol causes neuropathy via multifactorial processes, many of which are still under investigation. Alcohol enters the bloodstream from the digestive system within 5 minutes of consumption, and peak absorption is seen within 30 to 90 minutes. One of the many inhibitory effects of chronic alcohol use is malnutrition. Patients who abuse alcohol tend to consume fewer calories and have poor absorption of nutrients in the gastrointestinal tract. There are also direct toxic effects of alcohol and its metabolites on neurons affecting cellular cytoskeletons and demyelination of neurons.
One of the key nutrients inhibited by alcohol is thiamine, vitamin-B1. Thiamine serves as an important coenzyme in carbohydrate metabolism and neuron development. The lack of thiamine in the nervous system affects the cellular structure and can cause cell membrane damage and irregular ectopic cells. Other vitamin deficiencies seen with alcohol abuse include, but are not limited to, B-vitamins, folic acid, and vitamin-E. Poor absorption and low intake of these vitamins have clinical features of dermatitis, neuropathy, and anorexia.
Other studies have shown a direct, negative effect from alcohol and its many metabolites on the nervous system. Axonal degeneration and demyelination of neurons were seen in both humans and lab mice receiving alcohol. The cause is a diverse multifactorial process caused from damage by free radicals, the release of inflammatory markers, and oxidative stress.
A thorough history and physical is key when evaluating patients with alcohol use disorder. Screening patients for alcohol abuse and alcohol consumption is very important. Many patients may not mention alcohol consumption when interviewed and may present with neuropathy complaints only. Additional nutritional and diet questions should be investigated. The National Institute on Alcohol Abuse and Alcoholism recommends using the CAGE questionnaire to help identify a patient's potential problem with alcohol. CAGE questions include:
The two most important questions to ask when evaluating for alcohol neuropathy: (1) How much alcohol do you drink? and (2) What is the length of the abuse? These questions can help differential alcohol neuropathy from other forms of neuropathy. Screening for other disease processes that may cause neuropathy, such as diabetes, is also important.
Most patients with alcohol neuropathy initially present with symmetrical polyneuropathies in the lower distal extremities, however; heavier abuse can progress to distal upper extremity symptoms. The most common findings are sensory related and are varied to include pain, numbness, and paresthesias. Pain seems to be consistent through the literature to be one of the most common complaints and can be the first clinical indication of the disease. Keeping this disease process high on the differential with the right history is essential. Progression of the disease leads to symmetrical ascending motor and sensory deficits.
A complete neurological exam is imperative. Physical exam findings include diminished sensation to vibration, pain, dysfunctional thermo-proprioception, weakness in the ankle and toes with flexion and extension, atrophy of foot muscles, gait ataxia, and diminished deep tendon reflexes.
No specific tests diagnose this condition. History and physical are key to making the diagnosis. Some studies that may help rule in or out this condition include:
Treatment should be focused on therapy to stop alcohol abuse. The overall prognosis is favorable. Abstinence for several months up to a few years have shown both clinical examination and electroneurographic improvements, with most patients showing complete regain of function. Additional treatment includes replacing nutrients such as thiamine, vitamin-B12, and folic acid. Psychiatry referral, alcohol abstinence abuse programs, and support groups have shown favorable ways to help patients recover from alcohol use disorder. Physical therapy and occupational therapy can play a role in supporting the patient as they regain movement and perform everyday functions.
Many differential diagnoses are seen in other forms of neuropathies and chronic alcohol use disorder. These include but are not limited to the following:
Chronic alcohol consumption can have deleterious effects on the central and peripheral nervous systems. One of the most common adverse effects seen in patients with chronic alcohol use disorder is alcohol neuropathy. This commonly presents with pain, paresthesias, and ataxia in the distal lower extremities. The exact number of people affected by this condition is not known, but studies have shown that up to 66% of patients with chronic alcohol use disorder may have some form of the disease. The cause is multifactorial, from both nutritional deficiencies and alcohol metabolism's direct toxic effects on neurons. Because of the diverse effects of alcohol on the body, these patients should be managed by an interprofessional team. The management of alcoholic neuropathy is not satisfactory. The treatment rests on abstinence from alcohol and the replacement of key nutrients. Unfortunately, patient compliance is poor and the condition often progresses leading to poor quality of life. Even in patients who quit alcohol, residual neuropathy is common. (Level V)
|||Julian T,Glascow N,Syeed R,Zis P, Alcohol-related peripheral neuropathy: a systematic review and meta-analysis. Journal of neurology. 2018 Nov 22; [PubMed PMID: 30467601]|
|||Hammoud N,Jimenez-Shahed J, Chronic Neurologic Effects of Alcohol. Clinics in liver disease. 2019 Feb; [PubMed PMID: 30454828]|
|||Sun J,Chen F,Braun C,Zhou YQ,Rittner H,Tian YK,Cai XY,Ye DW, Role of curcumin in the management of pathological pain. Phytomedicine : international journal of phytotherapy and phytopharmacology. 2018 Sep 15; [PubMed PMID: 30195871]|
|||Pakdel F,Sanjari MS,Naderi A,Pirmarzdashti N,Haghighi A,Kashkouli MB, Erythropoietin in Treatment of Methanol Optic Neuropathy. Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society. 2018 Jun; [PubMed PMID: 29300238]|
|||Humbertjean-Selton L,Selton J,Riou-Comte N,Lacour JC,Mione G,Richard S, Bilateral optic neuropathy related to severe anemia in a patient with alcoholic cirrhosis: a case report and review of the literature. Clinical and molecular hepatology. 2018 Dec; [PubMed PMID: 29065678]|
|||Neary J,Goodwin SE,Cohen LB,Neuman MG, Alcohol Misuse Link to POEMS Syndrome in a Patient. Cancers. 2017 Sep 23; [PubMed PMID: 28946631]|
|||Hamel J,Logigian EL, Acute nutritional axonal neuropathy. Muscle [PubMed PMID: 28556429]|
|||Dervaux A,Laqueille X, [Thiamine (vitamin B1) treatment in patients with alcohol dependence]. Presse medicale (Paris, France : 1983). 2017 Mar; [PubMed PMID: 27818067]|
|||Zeng L,Alongkronrusmee D,van Rijn RM, An integrated perspective on diabetic, alcoholic, and drug-induced neuropathy, etiology, and treatment in the US. Journal of pain research. 2017; [PubMed PMID: 28176937]|
|||Di Ciaula A,Grattagliano I,Portincasa P, Chronic alcoholics retain dyspeptic symptoms, pan-enteric dysmotility, and autonomic neuropathy before and after abstinence. Journal of digestive diseases. 2016 Nov; [PubMed PMID: 27684550]|